Literature DB >> 24363478

Semiparametric Bayes hierarchical models with mean and variance constraints.

Mingan Yang1, David B Dunson2, Donna Baird3.   

Abstract

In parametric hierarchical models, it is standard practice to place mean and variance constraints on the latent variable distributions for the sake of identifiability and interpretability. Because incorporation of such constraints is challenging in semiparametric models that allow latent variable distributions to be unknown, previous methods either constrain the median or avoid constraints. In this article, we propose a centered stick-breaking process (CSBP), which induces mean and variance constraints on an unknown distribution in a hierarchical model. This is accomplished by viewing an unconstrained stick-breaking process as a parameter-expanded version of a CSBP. An efficient blocked Gibbs sampler is developed for approximate posterior computation. The methods are illustrated through a simulated example and an epidemiologic application.

Entities:  

Keywords:  Dirichlet process; Latent variables; Moment constraints; Nonparametric Bayes; Parameter expansion; Random effects

Year:  2010        PMID: 24363478      PMCID: PMC3869464          DOI: 10.1016/j.csda.2010.03.025

Source DB:  PubMed          Journal:  Comput Stat Data Anal        ISSN: 0167-9473            Impact factor:   1.681


  5 in total

1.  Bayesian latent variable models for median regression on multiple outcomes.

Authors:  David B Dunson; M Watson; Jack A Taylor
Journal:  Biometrics       Date:  2003-06       Impact factor: 2.571

2.  A semiparametric Bayesian approach to the random effects model.

Authors:  K P Kleinman; J G Ibrahim
Journal:  Biometrics       Date:  1998-09       Impact factor: 2.571

3.  Association between maternal serum concentration of the DDT metabolite DDE and preterm and small-for-gestational-age babies at birth.

Authors:  M P Longnecker; M A Klebanoff; H Zhou; J W Brock
Journal:  Lancet       Date:  2001-07-14       Impact factor: 79.321

4.  High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence.

Authors:  Donna Day Baird; David B Dunson; Michael C Hill; Deborah Cousins; Joel M Schectman
Journal:  Am J Obstet Gynecol       Date:  2003-01       Impact factor: 8.661

5.  Self-reported heavy bleeding associated with uterine leiomyomata.

Authors:  Ganesa Wegienka; Donna Day Baird; Irva Hertz-Picciotto; Siobán D Harlow; John F Steege; Michael C Hill; Joel M Schectman; Katherine E Hartmann
Journal:  Obstet Gynecol       Date:  2003-03       Impact factor: 7.661

  5 in total
  6 in total

1.  A Dirichlet process mixture model for survival outcome data: assessing nationwide kidney transplant centers.

Authors:  Lili Zhao; Jingchunzi Shi; Tempie H Shearon; Yi Li
Journal:  Stat Med       Date:  2015-01-26       Impact factor: 2.373

2.  DPpackage: Bayesian Non- and Semi-parametric Modelling in R.

Authors:  Alejandro Jara; Timothy E Hanson; Fernando A Quintana; Peter Müller; Gary L Rosner
Journal:  J Stat Softw       Date:  2011-04-01       Impact factor: 6.440

3.  Bayesian inference for longitudinal data with non-parametric treatment effects.

Authors:  Peter Müller; Fernando A Quintana; Gary L Rosner; Michael L Maitland
Journal:  Biostatistics       Date:  2013-11-26       Impact factor: 5.899

4.  A Bayesian modeling approach for generalized semiparametric structural equation models.

Authors:  Xin-Yuan Song; Zhao-Hua Lu; Jing-Heng Cai; Edward Hak-Sing Ip
Journal:  Psychometrika       Date:  2013-02-01       Impact factor: 2.500

5.  Estimating heterogeneous survival treatment effects of lung cancer screening approaches: A causal machine learning analysis.

Authors:  Liangyuan Hu; Jung-Yi Lin; Keith Sigel; Minal Kale
Journal:  Ann Epidemiol       Date:  2021-06-23       Impact factor: 6.996

6.  Individualized treatment effects with censored data via fully nonparametric Bayesian accelerated failure time models.

Authors:  Nicholas C Henderson; Thomas A Louis; Gary L Rosner; Ravi Varadhan
Journal:  Biostatistics       Date:  2020-01-01       Impact factor: 5.899

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.